Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciclesonide Nasal Aerosol in Children with Perennial Allergic Rhinitis
NCT01451541Phase 3Completed
- Sponsor
- Sumitomo Pharma America
- Start
- Oct 2011
- Primary completion
- Dec 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of ciclesonide in perennial allergic rhinitis (PAR), sponsored by Sumitomo Pharma America. Started Oct 2011; status: completed.
02
Drugs
ciclesonide
03
Conditions
perennial allergic rhinitis (PAR)
Beyond the preview
Go deeper on NCT01451541.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01451541.